![Michael R. Goldberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Michael R.
Goldberg joined Theravance, Inc. as Vice President of Clinical Pharmacology in September 2005.
From 1988 to 2005, he was Senior Director of Safety/Clinical Risk Management and Safety Surveillance for Merck and worked at Eli Lilly in the Clinical Pharmacology Department.
Dr. Goldberg received his MD and PhD degrees from Tulane University, School of Medicine and completed his Clinical Pharmacology fellowship at the Vanderbilt University School of Medicine.
Former positions of Michael R. Goldberg
| Companies | Position | End |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2005 |
| INNOVIVA, INC. | Corporate Officer/Principal | - |
Training of Michael R. Goldberg
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
97
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Innoviva, Inc.
 Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
Tulane University (Louisiana)
 Tulane University (Louisiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Michael R. Goldberg
